Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 5;12(11):2228.
doi: 10.3390/plants12112228.

Plant-Produced Nanoparticles Based on Artificial Self-Assembling Peptide Bearing the Influenza M2e Epitope

Affiliations

Plant-Produced Nanoparticles Based on Artificial Self-Assembling Peptide Bearing the Influenza M2e Epitope

Elena A Blokhina et al. Plants (Basel). .

Abstract

Despite advances in vaccine development, influenza remains a persistent global health threat and the search for a broad-spectrum recombinant vaccine against influenza continues. The extracellular domain of the transmembrane protein M2 (M2e) of the influenza A virus is highly conserved and can be used to develop a universal vaccine. M2e is a poor immunogen by itself, but it becomes highly immunogenic when linked to an appropriate carrier. Here, we report the transient expression of a recombinant protein comprising four tandem copies of M2e fused to an artificial self-assembling peptide (SAP) in plants. The hybrid protein was efficiently expressed in Nicotiana benthamiana using the self-replicating potato virus X-based vector pEff. The protein was purified using metal affinity chromatography under denaturing conditions. The hybrid protein was capable of self-assembly in vitro into spherical particles 15-30 nm in size. The subcutaneous immunization of mice with M2e-carrying nanoparticles induced high levels of M2e-specific IgG antibodies in serum and mucosal secretions. Immunization provided mice with protection against a lethal influenza A virus challenge. SAP-based nanoparticles displaying M2e peptides can be further used to develop a recombinant "universal" vaccine against influenza A produced in plants.

Keywords: M2e peptide; Nicotiana benthamiana; influenza A; nanoparticle; plant; self-assembling peptide; transient expression; vaccine; viral vector.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Expression vector and recombinant protein. Scheme of the expression vector (a). RDRP, RNA-dependent RNA polymerase gene; Sgp1, the first promoter of subgenomic RNA of PVX; AMV, translational enhancer from alfalfa mosaic virus; 35S, promoter of the cauliflower mosaic virus RNA; Nos-T, terminator of the A. tumefaciens nopaline synthase gene; P24, gene of suppressor of silencing from grapevine leafroll-associated virus-2. 6H, hexahistidine tag; 19S, flexible glycine-rich linker; SAP, self-assembling peptide; SP, rigid helical linker; 4M2eh, four tandem copies of M2e peptide; RB and LB, the right and left borders of T-DNA region. Models of the three-dimensional structure of monomeric 19S_SAP_Sp_4M2eh protein and nanoparticles composed of 60 monomers (b).
Figure 2
Figure 2
Expression of 19S_SAP_Sp_4M2eh protein in N. benthamiana plants. Coomassie brilliant blue-stained gel (a,c) and Western blotting with antibodies against M2e (b) of proteins isolated from plants. M, molecular weight marker (kD); Lanes: 1, total proteins isolated from non-infiltrated leaf; 2, total proteins isolated from leaf infiltrated with pEff/19S_SAP_Sp_4M2eh; 3, purified 19S_SAP_Sp_4M2eh protein. Position of 19S_SAP_Sp_4M2eh protein is shown by arrow. Photographs of N. benthamiana leaves infiltrated with pEff/19S_SAP_Sp_4M2eh on different dpi (d).
Figure 3
Figure 3
Analysis of virus-like particles formed by 19S_SAP_Sp_4M2eh protein by atomic force microscopy (a) and transmission electron microscopy (b).
Figure 4
Figure 4
Immunogenicity and protective efficiency of 19S_SAP_Sp_4M2eh nanoparticles. Titers of IgG antibodies to synthetic M2e peptide in sera (a) and BAL (b) of immunized mice after the third immunization. The values for 4 animals (circles and squares) and the geometric mean titers (horizontal lines) are shown. The survival rate (c) and body weight changes (d) of immunized and control (PBS) mice was monitored for 14 days post-challenge with 4 × LD50 of A/Aichi/2/68 (H3N2) influenza A virus.

References

    1. Chauhan R.P., Gordon M.L. An overview of influenza A virus genes, protein functions, and replication cycle highlighting important updates. Virus Genes. 2022;58:255–269. doi: 10.1007/s11262-022-01904-w. - DOI - PubMed
    1. Deng L., Cho K.J., Fiers W., Saelens X. M2e-Based Universal Influenza A Vaccines. Vaccines. 2015;3:105–136. doi: 10.3390/vaccines3010105. - DOI - PMC - PubMed
    1. Nachbagauer R., Krammer F. Universal influenza virus vaccines and therapeutic antibodies. Clin. Microbiol. Infect. 2017;23:222–228. doi: 10.1016/j.cmi.2017.02.009. - DOI - PMC - PubMed
    1. Fiers W., De Filette M., Birkett A., Neirynck S., Min Jou W. A “universal” human influenza A vaccine. Virus Res. 2004;103:173–176. doi: 10.1016/j.virusres.2004.02.030. - DOI - PubMed
    1. Neirynck S., Deroo T., Saelens X., Vanlandschoot P., Jou W.M., Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat. Med. 1999;5:1157–1163. doi: 10.1038/13484. - DOI - PubMed

LinkOut - more resources